H.R. 3568 (109th): Angie Fatino Save Our Children from Meth Act of 2005

Jul 28, 2005 (109th Congress, 2005–2006)
Died (Referred to Committee)
Tom Latham
Representative for Iowa's 4th congressional district
Read Text »
Last Updated
Jul 28, 2005
10 pages

This bill was introduced on July 28, 2005, in a previous session of Congress, but was not enacted.

Introduced Jul 28, 2005
Referred to Committee Jul 28, 2005
Full Title

To amend the Controlled Substances Act to provide for the transfer of ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances, and for other purposes.


No summaries available.

6 cosponsors (4D, 2R) (show)

House Energy and Commerce


House Judiciary

Crime, Terrorism, Homeland Security, and Investigations

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Angie Fatino Save Our Children from Meth Act of 2005 - Amends the Controlled Substances Act to direct the Attorney General to transfer to schedule V ephedrine, pseudoephedrine, and phenylpropanolamine.
Makes this provision inapplicable with respect to pseudoephedrine when contained in a product that is in a liquid, liquid capsule, or liquid-filled gel capsule, that does not contain more than 360 milligrams of pseudoephedrine, and that is approved under the Federal Food, Drug, and Cosmetic Act (pseudoephedrine contained in such product shall then be considered a list I chemical).
Revises the definition of "regulated transaction" to exclude specified transactions involving drugs or products that the Attorney General determines are being diverted for illicit purposes.
Places restrictions on the sale of list I and schedule V pseudoephedrine products.
Requires a registrant of list I products to:
(1) place the products where the customers do not have direct access to them;
(2) maintain a sales logbook that identifies the products, purchasers, dates, and times of sales; and
(3) not sell such a product to persons under age 18.
Prohibits a registrant of schedule V products that do not require prescriptions from dispensing such a product to a prospective purchaser under age 18.
Sets penalties for violations.
Prohibits any person from knowingly or intentionally purchasing at retail: (1) more than one list I pseudoephedrine product during a 24-hour period without a prescription; (2) more than 7,500 milligrams of pseudoephedrine in list I or schedule V products during a 30-day period without a prescription; or (3) such a list I product without legibly signing the appropriate logbook.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 3568 (109th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus